0 of 8 Questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 8 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. What is your degree?
2. What is your specialty?
3. How confident are you in the management of patients with severe asthma in your practice?
4. In a retrospective cohort study from 2012 to 2017, approximately what percentage of patients with GINA step 4 or 5 asthma were categorized as high OCS users (≥450 mg of OCS prescribed within a 90-day period during follow-up)?
5. The protective functions of the airway epithelium include which of the following?
6. IL-25, IL-33, and TSLP are released through which of the following inflammatory processes?
7. The 2022 GINA decision tree for difficult-to-treat and severe asthma in adults and adolescents indicates that higher FeNO may be a predictor of response for which of the following therapies?
8. Sara, a 36-year-old female, presents on 6-month follow-up after initiating IL-5 antibiotic and continuing high-dose ICS. Baseline eosinophils were 374/µL and FeNO was 51 ppb. Her IgE level was 25 IU/ml and allergy skin tests were negative. She has no notable comorbidities or atopic history. She was diagnosed with asthma at age 27. She continues to experience symptoms 2-3x/week with 1 exacerbation in the last 6 months and is concerned about continued impact to daily activities. What would be the most appropriate next step?